[1] |
Yu S, Liu R, Zhao G, et al. The prevalence and burden of primary headaches in china: a population-based door-to-door survey[J]. Headache, 2012, 52(4): 582-591.
|
[2] |
Yao C, Wang Y, Wang L, et al. Burden of headache disorders in china, 1990-2017: findings from the global burden of disease study 2017[J]. J Headache Pain, 2019, 20(1): 102.
|
[3] |
Korucu O, Dagar S, Çorbacioglu ŞK, et al. The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments[J]. Acta Neurol Scand, 2018, 138(3): 212-218.
|
[4] |
Gul HL, Ozon AO, Karadas O, et al. The efficacy of greater occipital nerve blockade in chronic migraine: a placebo-controlled study[J]. Acta Neurol Scand, 2017, 136(2): 138-144.
|
[5] |
Cuadrado ML, Aledo-Serrano Á, Navarro P, et al. Short-term effects of greater occipital nerve blocks in chronic migraine: a double-blind, randomised, placebo-controlled clinical trial[J]. Cephalalgia, 2017, 37(9): 864-872.
|
[6] |
Özer D, Bölük C, Türk Börü Ü, et al. Greater occipital and supraorbital nerve blockade for the preventive treatment of migraine: a single-blind, randomized, placebo-controlled study[J]. Curr Med Res Opin, 2019, 35(5): 909-915.
|
[7] |
张君,李剑峰,高文静,等.神经妥乐平联合星状神经节阻滞治疗偏头痛的临床研究[J].中国实用神经疾病杂志, 2017, 20(12): 103-104.
|
[8] |
王慧颖,李红亮,王保国.星状神经节阻滞治疗偏头痛的有效性及安全性分析及其对头颈部动脉血流动力学的影响[J].中国医药导报, 2017, 14(21): 25-28, 49.
|
[9] |
姜烨容,霍然. A型肉毒毒素的临床研究进展[J].中华损伤与修复杂志(电子版), 2017, 12(4): 298-302.
|
[10] |
Binder WJ, Brin MF, Blitzer A, et al. Botulinum toxin type a (BOTOX) for treatment of migraine headaches: an open-label study[J]. Otolaryngol Head Neck Surg, 2000, 123(6): 669-676.
|
[11] |
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type a in pain management[J]. Headache, 2003, 43 Suppl: S9-S15.
|
[12] |
Castrillo Sanz A, Morollón Sánchez-Mateos N, Simonet Hernández C, et al. Experience with botulinum toxin in chronic migraine[J]. Neurologia, 2018, 33(8): 499-504.
|
[13] |
Shen B, Wang L. Impact of the botulinum-a toxin on prevention of adult migraine disorders[J]. J Integr Neurosci, 2020, 19(1): 201-208.
|
[14] |
Yuan H, Silberstein SD. The use of botulinum toxin in the management of headache disorders[J]. Handb Exp Pharmacol, 2021, 263: 227-249.
|
[15] |
Goadsby PJ, Grosberg BM, Mauskop A, et al. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study[J]. Cephalalgia, 2014, 34(12): 986-993.
|
[16] |
屈箫箫,邵娣,杨开洋.经皮耳迷走神经刺激预防性治疗偏头痛的临床疗效观察[J].陕西医学杂志, 2017, 46(9): 1255-1257.
|
[17] |
Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study[J]. Neurology, 2018, 91(4): e3t64-e373.
|
[18] |
Diener HC, Goadsby PJ, Ashina M, et al. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial[J]. Cephalalgia, 2019, 39(12): 1475-1487.
|
[19] |
Zhang Y, Liu J, Li H, et al. Transcutaneous auricular vagus nerve stimulation at 1 Hz modulates locus coeruleus activity and resting state functional connectivity in patients with migraine: an fMRI study[J]. Neuroimage Clin, 2019, 24: 101971.
|
[20] |
Hawkins JL, Cornelison LE, Blankenship BA, et al. Vagus nerve stimulation inhibits trigeminal nociception in a rodent model of episodic migraine[J]. Pain Rep, 2017, 2(6): e628.
|
[21] |
Chou DE, Shnayderman Yugrakh M, Winegarner D, et al. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial[J]. Cephalalgia, 2019, 39(1): 3-14.
|
[22] |
Beh SC. External trigeminal nerve stimulation: potential rescue treatment for acute vestibular migraine[J]. J Neurol Sci, 2020, 408: 116550.
|
[23] |
Lan L, Zhang X, Li X, et al. The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails[J]. J Headache Pain, 2017, 18(1): 86.
|
[24] |
Guyuron B, Kriegler JS, Davis J, et al. Five-year outcome of surgical treatment of migraine headaches[J]. Plast Reconstr Surg, 2011, 127(2): 603-608.
|
[25] |
金永健,冯增伟,李丹,等.显微血管减压术治疗偏头痛及预后分析[J].中华神经外科杂志, 2012, 28(2): 186-188.
|
[26] |
孙鹏,张重功,魏原勇.微创手术治疗顽固性偏头痛22例疗效观察[J].中西医结合心脑血管病杂志, 2014(12): 1526-1527.
|
[27] |
籍彦生,雷国亮,李奎智,等.颞浅动脉型偏头痛不同手术方法的疗效对比研究[J].河北医科大学学报, 2015, 36(5): 576-578.
|
[28] |
周庆明,潘海鹏,金永健,等.神经血管减压术治疗偏头痛的临床研究[J].中国实用医药, 2020, 15(26): 31-34.
|
[29] |
Jose A, Nagori SA, Roychoudhury A. Surgical management of migraine headache[J]. J Craniofac Surg, 2018, 29(2): e106-e108.
|
[30] |
Amaya-Blas FJ, Mecott GA, Marfil-Rivera A, et al. Effectiveness of surgical treatment in chronic migraine[J]. Cir Cir, 2019, 86(1): 90-95.
|
[31] |
Wormald JCR, Luck J, Athwal B, et al. Surgical intervention for chronic migraine headache: a systematic review[J]. JPRAS Open, 2019, 20: 1-18.
|
[32] |
于生元,万琪,王伟,等.偏头痛非药物防治中国专家共识[J].神经损伤与功能重建, 2021, 16(1): 1-5.
|
[33] |
Xu S, Yu L, Luo X, et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial[J]. BMJ, 2020, 368: m697.
|
[34] |
Zhao L, Chen J, Li Y, et al. The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial[J]. JAMA Intern Med, 2017, 177(4): 508-515.
|
[35] |
Xu J, Zhang FQ, Pei J, et al. Acupuncture for migraine without aura: a systematic review and meta-analysis[J]. J Integr Med, 2018, 16(5): 312-321.
|
[36] |
Yang M, Du T, Long H, et al. Acupuncture for menstrual migraine: a systematic review[J]. BMJ Support Palliat Care, 2020, Online ahead of print.
|